Repository set up for Steve Kern and colleagues at Global Health Labs to model improved triage/diagnostics for cervical cancer screening.
Two scenarios to model:
- Impact on elimination targets with an AVE with an accurate means to detect CIN2/3 and ablate. Compare to VIA to assess differential value.
- Value of a diagnostic with NAAT detection ability in a disposable LFA-type package that costs <$2 and gives an answer in 15 mins. Compare to TxVx with mass vaccination of 25-45 year olds. Would it make a difference if this test could do genotyping?
To run analyses and reproduce results:
Part 1: AVE test characteristics
- Run
run_sweeps.py
withrun_sweeps
uncommented - Run
run_sweeps.py
withplot_sweeps
uncommented
Part 2: POC HPV+AVE vs. TxVx TODO